TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biocell AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
3,745 |
| Financial expenses |
0
|
180
|
0 |
| Earnings before taxes |
10
|
107
|
1,028 |
| EBITDA |
-65
|
-60
|
488 |
| Total assets |
1,295
|
1,399
|
1,586 |
| Current assets |
730
|
973
|
1,127 |
| Current liabilities |
174
|
266
|
430 |
| Equity capital |
1,121
|
1,133
|
1,156 |
| - share capital |
90
|
90
|
98 |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.6%
|
81.0%
|
72.9% |
| Turnover per employee | 3,745 | ||
| Profit as a percentage of turnover | 27.4% | ||
| Return on assets (ROA) |
0.8%
|
20.5%
|
64.8% |
| Current ratio |
419.5%
|
365.8%
|
262.1% |
| Return on equity (ROE) |
0.9%
|
9.4%
|
88.9% |
| Change turnover |
0
|
-3,441
|
240 |
| Change turnover % |
-100%
|
7% | |
| Chg. No. of employees |
0
|
-1
|
1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.